Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
News

Ontario hosts roundtable on genetics and gene patenting

Don Willison
CMAJ March 05, 2002 166 (5) 645;
Don Willison
Centre for Evaluation of Medicines, McMaster University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site

Ontario took a step toward establishing a framework for genetics and gene patenting during a recent meeting on the role of genetics in the diagnosis, prevention and treatment of disease.

“We need to ensure that the transformations in genetics … are guided by a national framework rooted in our social and ethical values that can benefit all Canadians [in order] to ensure the sustainability of a publicly funded health care system,” said Tony Clement, Ontario's minister of health and long-term care.

The meeting of scientists, clinicians, consumers and others was chaired by Dr. David Naylor, dean of medicine at the University of Toronto. It touched upon a wide range of issues, including discrimination and access to information, gene patenting and financial implications for the publicly funded health system.

Particularly contentious was the issue of gene patents. Richard Gold of McGill University's Faculty of Law asserted that the role of patents in promoting innovation is overstated and that governments should be prepared to exercise their rights to grant compulsory licences to protect public health and, in particular, to promote access to medicines for all. These views were hotly contested by business and industry representatives, who argued that the protection of intellectual property rights is central to the promotion of innovation.

In April 2000, Ontario established an advisory committee to recommend a framework for the introduction of new predictive genetic technologies into the health care system. Its report was submitted last November – 5 months ahead of schedule – and is currently on the minister's desk.

Concern over new genetic technologies grew last May when the Ontario government was warned by Myriad Genetic Laboratories that any predictive testing for the BRCA1 and BRCA2 genes outside its laboratories violated the company's patents on the 2 genes (see CMAJ 2002;166[4]:494).

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

Powered by HighWire